ANOVA PANCAN result package

Francesco Iorio, EMBL - European Bioinformatics Institute
result parsing started on 2016-03-31 19:01:08
iorio@ebi.ac.uk


Drug Domain: GDSC1000_paper_set, Analysis Domain: panCancer


Individual drug analysis: 1049


Drug details and screening numbers

Drug Name: PD-173074
Drug ID: 1049
Synonyms: PD-173074
Brand name:
Target: FGFR1, FGFR3

Number of cell lines screened: 849
Screening concentration range(s): 0.0078125 to 2 uM


Statistically significant associations identified = 4
association id
FEATURE
Drug id
Propr
Public
Drug Name
Drug Target
N FEATURE pos
N FEATURE neg
log max Conc tested
FEATURE neg logIC50 MEAN
FEATURE pos logIC50 MEAN
FEATURE deltaMEAN IC50
FEATURE IC50 effectSize
FEATURE neg Glass delta
FEATURE pos Glass delta
ANOVA FEATURE pval
Tissue ANOVA pval
MSI ANOVA pval
ANOVA FEATURE FDR %
a86
RUNX1_mut
1049
1
1
PD-173074
FGFR1, FGFR3
3
843
0.693
2.59
-0.0793
-2.67
2.4 **
2.4 **
0.91 .
5.86e-06
1.23e-20
1.9e-01
1.1
a384
loss_cnaPANCAN167
1049
1
1
PD-173074
FGFR1, FGFR3
19
827
0.693
2.57
3.3
0.731
0.66 .
0.66 .
0.96 .
4.07e-04
2.24e-20
1.92e-01
18
a468
loss_cnaPANCAN98
1049
1
1
PD-173074
FGFR1, FGFR3
79
767
0.693
2.53
3.11
0.583
0.53 .
0.52 .
0.7 .
6.11e-04
2.37e-20
1.93e-01
22
a522
gain_cnaPANCAN301_(CDK12,ERBB2,MED24)
1049
1
1
PD-173074
FGFR1, FGFR3
47
799
0.693
2.55
3.16
0.61
0.55 .
0.55 .
0.83 .
7.8e-04
2.45e-20
1.93e-01
25


All-tests volcano plot